CLINICAL_TRIALS
trial_result
· 2012-02-09
Clinical Trial Update: Phase I Study of Intravenous Lipotecan® (TLC388 HCl for Injection) in Patients With Advanced Solid Tumors [Phase 1]
Summary
Phase I study of intravenous Lipotecan (TLC388 HCl) in patients with advanced solid tumors completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Taiwan Liposome Company | Conditions: Advanced Solid Tumors | Phase 1 | Status: COMPLETED | Results posted: 2012-02-09